
    
      Protocol 04-001-01

      The primary objective of the study is to assess, under controlled conditions, the safety and
      efficacy of an experimental anti-anxiety medication relative to placebo in subjects with
      generalized anxiety disorder (GAD).

      The secondary objective of the study is to study algorithms for discontinuation of an
      experimental anti-anxiety medication.

      Recruiting: Participants are currently being recruited and enrolled.
    
  